サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1500817

睡眠補助薬市場：世界の産業分析、規模、シェア、成長、動向、2024年～2033年予測

Sleep Aids Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日: | 発行: Persistence Market Research | ページ情報: 英文 164 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
睡眠補助薬市場：世界の産業分析、規模、シェア、成長、動向、2024年～2033年予測
出版日: 2024年06月20日
発行: Persistence Market Research
ページ情報: 英文 164 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、世界の睡眠補助薬市場に関する包括的なレポートを発表しました。当レポートでは、市場促進要因・動向・機会・課題など、重要な市場ダイナミクスを徹底的に評価し、市場構造に関する詳細な洞察を提供しています。この調査レポートは、2024年から2033年までの世界の睡眠補助薬市場の予測成長軌道を概説する独占データと統計を掲載しています。

主な洞察

  • 睡眠補助薬の市場規模（2024E）：296億米ドル
  • 予測市場価値（2033F）：432億米ドル
  • 世界市場成長率（CAGR 2024年～2033年）：4.3%：4.3%

睡眠補助薬市場：調査範囲

睡眠補助薬は、不眠症、睡眠時無呼吸症候群、レストレスレッグス症候群、睡眠の質に影響を及ぼすその他の症状など、様々な睡眠障害の管理において重要な役割を果たしています。睡眠補助薬には、睡眠パターンの改善、睡眠時間の延長、睡眠全般の健康促進を目的とした様々な製品や治療法が含まれます。睡眠補助薬市場は、医薬品、医療機器、行動療法を通じて多様な層に対応し、慢性的な睡眠問題と臨時的な睡眠問題の両方に対応しています。

市場成長の促進要因：

世界の睡眠補助薬市場は、ライフスタイルの変化、ストレス、高齢化による睡眠障害の有病率の増加など、いくつかの重要な要因によって牽引されています。睡眠衛生の重要性とそれが健康全般に及ぼす影響に対する意識の高まりが、効果的な睡眠補助薬への需要を高めています。睡眠追跡装置、ウェアラブル技術、個別化睡眠療法などの技術の進歩により、治療成績と患者のアドヒアランスが向上しています。さらに、遠隔医療やデジタルヘルスプラットフォームの受け入れ拡大により、睡眠評価や治療への遠隔アクセスが容易になり、市場範囲が拡大しています。

市場の抑制要因：

有望な成長が見込まれるもの、睡眠補助薬市場は、規制当局の承認、特定の薬剤の長期使用に伴う安全性の懸念、非薬理学的介入の有効性のばらつきなどに関連する課題に直面しています。睡眠補助薬の承認と販売に関する厳しい規制は、メーカーやヘルスケアプロバイダーにコンプライアンス上の負担を課し、市場参入戦略や運営コストに影響を与えます。また、地域によっては睡眠障害治療に対する償還範囲が限られていることも、特に新興経済圏では市場浸透の障壁となっています。

市場機会：

睡眠補助薬市場は、睡眠診断や治療方法における技術革新によって大きな成長機会がもたらされます。神経刺激装置、認知行動療法、新規の薬理学的薬剤の進歩により、臨床医と患者が利用できる治療選択肢が拡大しています。さらに、睡眠研究における人工知能（AI）とビッグデータ分析の統合は、個別化された治療計画と睡眠障害の予測的洞察を促進しています。新たな機会を活用し、進化する規制状況を乗り切るためには、ヘルスケアプロバイダー、技術開発者、規制機関の戦略的協力が不可欠です。

本レポートで扱う主な質問

  • 世界の睡眠補助薬市場の成長を促す主な要因は何か？
  • どのような種類の睡眠補助薬や治療アプローチが、さまざまな層で支持を集めているか？
  • 技術の進歩は睡眠補助薬市場の競合情勢をどのように変えているか？
  • 睡眠補助薬市場に貢献している主要プレーヤーは誰か、また市場の関連性を維持するためにどのような戦略を採用しているか？
  • 世界の睡眠補助薬市場の新たな動向と将来展望は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 市場イノベーション/開発動向

第4章 重要成功要因

  • 製品採用分析
  • 主な規制
  • 疾病疫学
  • パイプライン評価
  • 最近の製品の発売/承認
  • PESTEL分析
  • ポーターの分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 製品別
    • 適応症別
    • 流通チャネル別
    • 国別
  • 2024年の市場シナリオ

第7章 世界の睡眠補助薬市場の需要（価値または規模）分析

  • 2019年～2023年の市場金額の歴史的分析
  • 現在および将来の市場金額予測、2024年～2033年
    • 前年比成長動向分析
    • 絶対的な機会分析

第8章 世界の睡眠補助薬市場分析（製品別）

  • イントロダクション/主な調査結果
  • 2019年～2023年製品別市場規模の過去分析
  • 現在および将来の市場規模の分析と予測、製品別、2024年～2033年
    • 薬物
      • 不眠症治療薬
        • ドキセピン塩酸塩
        • エスゾピクロン
        • ラメルテオン
        • トリアゾラム
        • ザレプロン
        • クアゼパム
        • その他
      • ナルコレプシー治療薬
        • モダフィニル
        • オキシベートナトリウム
        • アモダフィニル
        • その他
    • デバイス
      • CPAP装置
      • BiPAPデバイス
      • APAPデバイス
    • その他
      • マットレスと枕
      • チンストラップ
      • マウスピースと鼻用器具
  • 製品別市場の魅力分析

第9章 世界の睡眠補助薬市場分析（適応症別）

  • イントロダクション/主な調査結果
  • 過去の市場規模分析、適応症別、2019年～2023年
  • 現在および将来の市場規模の分析と予測、適応症別、2024年～2033年
    • 不眠症
    • 睡眠不足
    • ナルコレプシー
    • 睡眠時無呼吸
    • その他
  • 適応症別の市場の魅力分析

第10章 世界の睡眠補助薬市場分析（流通チャネル別）

  • イントロダクション/主な調査結果
  • 過去の市場規模分析、流通チャネル別、2019年～2023年
  • 現在および将来の市場規模の分析と予測、流通チャネル別、2024年～2033年
    • 病院薬局
    • 小売薬局
    • 電子商取引
    • ドラッグストア
    • その他
  • 流通チャネル別市場の魅力分析

第11章 地域別世界の睡眠補助薬市場分析

  • イントロダクション
  • 地域別市場規模の過去分析、2019年～2023年
  • 現在および将来の市場金額の分析と予測、2024年～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東およびアフリカ（中東・アフリカ）
  • 地域別市場の魅力分析

第12章 北米の睡眠補助薬市場分析

第13章 ラテンアメリカの睡眠補助薬市場分析

第14章 欧州の睡眠補助薬市場分析

第15章 東アジアの睡眠補助薬市場分析

第16章 南アジアの睡眠補助薬市場分析

第17章 オセアニアの睡眠補助薬市場

第18章 中東およびアフリカ（中東・アフリカ）睡眠補助薬市場分析

第19章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第20章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • ResMed Inc.
    • Koninklijke Philips NV
    • Merck &Co. Inc.
    • Drive DeVilbiss Healthcare LLC
    • GlaxoSmithKline Plc.
    • Fisher &Paykel Healthcare Limited
    • Sanofi SA
    • Pfizer Inc

第21章 使用される仮定と頭字語

第22章 調査手法

目次
Product Code: PMRREP2832

Persistence Market Research has recently released a comprehensive report on the worldwide Sleep Aids Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global Sleep Aids Market from 2024 to 2033.

Key Insights:

  • Sleep Aids Market Size (2024E): USD 29.6 Billion
  • Projected Market Value (2033F): USD 43.2 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 4.3%

Sleep Aids Market - Report Scope:

Sleep aids play a crucial role in managing various sleep disorders, including insomnia, sleep apnea, restless legs syndrome, and other conditions affecting sleep quality. These aids encompass a spectrum of products and therapies designed to improve sleep patterns, enhance sleep duration, and promote overall sleep health. The sleep aids market caters to diverse demographics through pharmaceuticals, medical devices, and behavioral therapies, addressing both chronic and occasional sleep issues.

Market Growth Drivers:

The global sleep aids market is driven by several key factors, including increasing prevalence of sleep disorders due to lifestyle changes, stress, and aging population. Rising awareness about the importance of sleep hygiene and its impact on overall health is amplifying demand for effective sleep aids. Technological advancements in sleep tracking devices, wearable technologies, and personalized sleep therapies are enhancing treatment outcomes and patient adherence. Moreover, the growing acceptance of telemedicine and digital health platforms is facilitating remote access to sleep evaluation and treatment, thereby expanding market reach.

Market Restraints:

Despite promising growth prospects, the sleep aids market faces challenges related to regulatory approvals, safety concerns associated with long-term use of certain medications, and variable efficacy of non-pharmacological interventions. Stringent regulations governing the approval and marketing of sleep aid products impose compliance burdens on manufacturers and healthcare providers, influencing market entry strategies and operational costs. Limited reimbursement coverage for sleep disorder treatments in some regions also poses a barrier to market penetration, particularly in emerging economies.

Market Opportunities:

The sleep aids market presents significant growth opportunities driven by technological innovations in sleep diagnostics and treatment modalities. Advancements in neurostimulation devices, cognitive behavioral therapies, and novel pharmacological agents are expanding the therapeutic options available to clinicians and patients. Furthermore, the integration of artificial intelligence (AI) and big data analytics in sleep research is facilitating personalized treatment plans and predictive insights into sleep disorders. Strategic collaborations between healthcare providers, technology developers, and regulatory bodies are essential to capitalize on emerging opportunities and navigate the evolving regulatory landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the sleep aids market globally?
  • Which types of sleep aids and therapeutic approaches are gaining traction across different demographics?
  • How are technological advancements reshaping the competitive landscape of the sleep aids market?
  • Who are the key players contributing to the sleep aids market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global sleep aids market?

Competitive Intelligence and Business Strategy:

Leading players in the global sleep aids market, including pharmaceutical companies, medical device manufacturers, and digital health innovators, focus on innovation, clinical research, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop next-generation sleep aid products, such as advanced pharmaceutical formulations, wearable sleep monitors, and AI-driven sleep management platforms. Collaborations with sleep clinics, academic institutions, and regulatory agencies facilitate product development, market access, and patient education initiatives. Moreover, emphasis on evidence-based practice and patient-centric care fosters market growth and improves treatment outcomes in the dynamic sleep aids landscape.

Key Companies Profiled:

  • ResMed Inc.
  • Koninklijke Philips N.V.
  • Merck & Co. Inc.
  • Drive DeVilbiss Healthcare LLC
  • GlaxoSmithKline Plc.
  • Fisher & Paykel Healthcare Limited
  • Sanofi SA
  • Pfizer Inc.

Key Segments Covered in Global Industry Research

Product:

  • Drugs
  • Devices

Indication:

  • Insomnia
  • Sleep Deprivation
  • Narcolepsy
  • Sleep Apnea

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • e commerce
  • Drug Stores

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Market Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. Key Regulations
  • 4.3. Disease Epidemiology
  • 4.4. Pipeline Assessment
  • 4.5. Recent Product launches/ Approvals
  • 4.6. PESTEL Analysis
  • 4.7. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Sleep Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increase in R&D Spending
    • 5.2.2. Rising Population with Sleep Disorders
    • 5.2.3. Growing Lifestyle Disease Prevalence
    • 5.2.4. Cost of Products
    • 5.2.5. Product Features
    • 5.2.6. Advancements in Technology
    • 5.2.7. Changes in Regulatory Policies
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Indication
    • 6.1.3. By Distribution Channel
    • 6.1.4. By Country
  • 6.2. 2024 Market Scenario

7. Global Sleep Aids Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis By Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product, 2024-2033
    • 8.3.1. Drugs
      • 8.3.1.1. Insomnia Treatment Drugs
        • 8.3.1.1.1. Doxepin Hydrochloride
        • 8.3.1.1.2. Eszopiclone
        • 8.3.1.1.3. Ramelteon
        • 8.3.1.1.4. Triazolam
        • 8.3.1.1.5. Zaleplon
        • 8.3.1.1.6. Quazepam
        • 8.3.1.1.7. Others
      • 8.3.1.2. Narcolepsy Treatment Drugs
        • 8.3.1.2.1. Modafinil
        • 8.3.1.2.2. Sodium Oxybate
        • 8.3.1.2.3. Armodafinil
        • 8.3.1.2.4. Others
    • 8.3.2. Devices
      • 8.3.2.1. CPAP Devices
      • 8.3.2.2. BiPAP Devices
      • 8.3.2.3. APAP Devices
    • 8.3.3. Others
      • 8.3.3.1. Mattresses and Pillows
      • 8.3.3.2. Chin Straps
      • 8.3.3.3. Mouth Pieces and Nasal Devices
  • 8.4. Market Attractiveness Analysis By Product

9. Global Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Indication, 2024-2033
    • 9.3.1. Insomnia
    • 9.3.2. Sleep Deprivation
    • 9.3.3. Narcolepsy
    • 9.3.4. Sleep Apnea
    • 9.3.5. Others
  • 9.4. Market Attractiveness Analysis By Indication

10. Global Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channel

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Distribution Channel, 2024-2033
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. e commerce
    • 10.3.4. Drug Stores
    • 10.3.5. Others
  • 10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 11.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Product
    • 12.3.3. By Indication
    • 12.3.4. By Distribution Channel
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Indication
    • 12.4.4. By Distribution Channel
  • 12.5. Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Key Players - Intensity Mapping
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. U.S. Sleep Aids Market Analysis
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Product
        • 12.8.1.2.2. By Indication
        • 12.8.1.2.3. By Distribution Channel
    • 12.8.2. Canada Sleep Aids Market Analysis
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Product
        • 12.8.2.2.2. By Indication
        • 12.8.2.2.3. By Distribution Channel

13. Latin America Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Product
    • 13.3.3. By Indication
    • 13.3.4. By Distribution Channel
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Indication
    • 13.4.4. By Distribution Channel
  • 13.5. Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Key Players - Intensity Mapping
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Mexico Sleep Aids Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By Indication
        • 13.8.1.2.3. By Distribution Channel
    • 13.8.2. Brazil Sleep Aids Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By Indication
        • 13.8.2.2.3. By Distribution Channel
    • 13.8.3. Argentina Sleep Aids Market Analysis
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Product
        • 13.8.3.2.2. By Indication
        • 13.8.3.2.3. By Distribution Channel

14. Europe Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Indication
    • 14.4.4. By Distribution Channel
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Players - Intensity Mapping
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Germany Sleep Aids Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Indication
        • 14.8.1.2.3. By Distribution Channel
    • 14.8.2. Italy Sleep Aids Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Indication
        • 14.8.2.2.3. By Distribution Channel
    • 14.8.3. France Sleep Aids Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By Indication
        • 14.8.3.2.3. By Distribution Channel
    • 14.8.4. U.K. Sleep Aids Market Analysis
      • 14.8.4.1. Introduction
      • 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.4.2.1. By Product
        • 14.8.4.2.2. By Indication
        • 14.8.4.2.3. By Distribution Channel
    • 14.8.5. Spain Sleep Aids Market Analysis
      • 14.8.5.1. Introduction
      • 14.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.5.2.1. By Product
        • 14.8.5.2.2. By Indication
        • 14.8.5.2.3. By Distribution Channel
    • 14.8.6. BENELUX Sleep Aids Market Analysis
      • 14.8.6.1. Introduction
      • 14.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.6.2.1. By Product
        • 14.8.6.2.2. By Indication
        • 14.8.6.2.3. By Distribution Channel
    • 14.8.7. Russia Sleep Aids Market Analysis
      • 14.8.7.1. Introduction
      • 14.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.7.2.1. By Product
        • 14.8.7.2.2. By Indication
        • 14.8.7.2.3. By Distribution Channel

15. East Asia Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Indication
    • 15.4.4. By Distribution Channel
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Players - Intensity Mapping
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. China Sleep Aids Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Indication
        • 15.8.1.2.3. By Distribution Channel
    • 15.8.2. Japan Sleep Aids Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Indication
        • 15.8.2.2.3. By Distribution Channel
    • 15.8.3. South Korea Sleep Aids Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Indication
        • 15.8.3.2.3. By Distribution Channel

16. South Asia Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Indication
    • 16.4.4. By Distribution Channel
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Players - Intensity Mapping
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. India Sleep Aids Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Indication
        • 16.8.1.2.3. By Distribution Channel
    • 16.8.2. Indonesia Sleep Aids Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Indication
        • 16.8.2.2.3. By Distribution Channel
    • 16.8.3. Malaysia Sleep Aids Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Indication
        • 16.8.3.2.3. By Distribution Channel
    • 16.8.4. Thailand Sleep Aids Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Indication
        • 16.8.4.2.3. By Distribution Channel

17. Oceania Sleep Aids Market 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Product
    • 17.3.3. By Indication
    • 17.3.4. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Indication
    • 17.4.4. By Distribution Channel
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Players - Intensity Mapping
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. Australia Sleep Aids Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Indication
        • 17.8.1.2.3. By Distribution Channel
    • 17.8.2. New Zealand Sleep Aids Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Indication
        • 17.8.2.2.3. By Distribution Channel

18. Middle East and Africa (MEA) Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. North Africa
      • 18.3.1.4. South Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Indication
    • 18.4.4. By Distribution Channel
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Key Players - Intensity Mapping
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. GCC Countries Sleep Aids Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Indication
        • 18.8.1.2.3. By Distribution Channel
    • 18.8.2. Turkey Sleep Aids Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Indication
        • 18.8.2.2.3. By Distribution Channel
    • 18.8.3. South Africa Sleep Aids Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Indication
        • 18.8.3.2.3. By Distribution Channel
    • 18.8.4. North Africa Sleep Aids Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.4.2.1. By Product
        • 18.8.4.2.2. By Indication
        • 18.8.4.2.3. By Distribution Channel

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. ResMed Inc.
      • 20.3.1.1. Overview
      • 20.3.1.2. Product Portfolio
      • 20.3.1.3. Sales Footprint
      • 20.3.1.4. Key Financials
      • 20.3.1.5. SWOT Analysis
      • 20.3.1.6. Strategy Overview
        • 20.3.1.6.1. Marketing Strategy
        • 20.3.1.6.2. Product Strategy
        • 20.3.1.6.3. Channel Strategy
    • 20.3.2. Koninklijke Philips N.V.
      • 20.3.2.1. Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Sales Footprint
      • 20.3.2.4. Key Financials
      • 20.3.2.5. SWOT Analysis
      • 20.3.2.6. Strategy Overview
        • 20.3.2.6.1. Marketing Strategy
        • 20.3.2.6.2. Product Strategy
        • 20.3.2.6.3. Channel Strategy
    • 20.3.3. Merck & Co. Inc.
      • 20.3.3.1. Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Sales Footprint
      • 20.3.3.4. Key Financials
      • 20.3.3.5. SWOT Analysis
      • 20.3.3.6. Strategy Overview
        • 20.3.3.6.1. Marketing Strategy
        • 20.3.3.6.2. Product Strategy
        • 20.3.3.6.3. Channel Strategy
    • 20.3.4. Drive DeVilbiss Healthcare LLC
      • 20.3.4.1. Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Sales Footprint
      • 20.3.4.4. Key Financials
      • 20.3.4.5. SWOT Analysis
      • 20.3.4.6. Strategy Overview
        • 20.3.4.6.1. Marketing Strategy
        • 20.3.4.6.2. Product Strategy
        • 20.3.4.6.3. Channel Strategy
    • 20.3.5. GlaxoSmithKline Plc.
      • 20.3.5.1. Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Sales Footprint
      • 20.3.5.4. Key Financials
      • 20.3.5.5. SWOT Analysis
      • 20.3.5.6. Strategy Overview
        • 20.3.5.6.1. Marketing Strategy
        • 20.3.5.6.2. Product Strategy
        • 20.3.5.6.3. Channel Strategy
    • 20.3.6. Fisher & Paykel Healthcare Limited
      • 20.3.6.1. Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Sales Footprint
      • 20.3.6.4. Key Financials
      • 20.3.6.5. SWOT Analysis
      • 20.3.6.6. Strategy Overview
        • 20.3.6.6.1. Marketing Strategy
        • 20.3.6.6.2. Product Strategy
        • 20.3.6.6.3. Channel Strategy
    • 20.3.7. Sanofi SA
      • 20.3.7.1. Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Sales Footprint
      • 20.3.7.4. Key Financials
      • 20.3.7.5. SWOT Analysis
      • 20.3.7.6. Strategy Overview
        • 20.3.7.6.1. Marketing Strategy
        • 20.3.7.6.2. Product Strategy
        • 20.3.7.6.3. Channel Strategy
    • 20.3.8. Pfizer Inc
      • 20.3.8.1. Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Sales Footprint
      • 20.3.8.4. Key Financials
      • 20.3.8.5. SWOT Analysis
      • 20.3.8.6. Strategy Overview
        • 20.3.8.6.1. Marketing Strategy
        • 20.3.8.6.2. Product Strategy
        • 20.3.8.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology